USRM OTC
U.S. Stem Cell, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -97.4%
5Y: -98.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$82K
-59.1% ▼
5Y CAGR: -56.9%
Gross Profit
$58K
-60.8% ▼
5Y CAGR: -56.2%
Operating Income
-$2M
+19.4% ▲
Net Income
-$3M
+13.1% ▲
EPS (Diluted)
$-0.00
+32.4% ▲
EBITDA
-$2M
+5.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $7M | $3M | $277K | $201K | $82K |
| YoY Growth | +21.4% | -54.2% | -91.0% | -27.6% | -59.1% |
| Cost of Revenue | $2M | $1M | $64K | $52K | $24K |
| Gross Profit | $5M | $2M | $213K | $149K | $58K |
| Gross Margin | 68.5% | 56.5% | 76.9% | 74.1% | 71.0% |
| R&D Expenses | $5K | $263 | $0 | $0 | $0 |
| SG&A Expenses | $6M | $4M | $3M | $2M | $2M |
| Operating Expenses | $6M | $5M | $3M | $2M | $2M |
| Operating Income | -$1M | -$3M | -$2M | -$2M | -$2M |
| Operating Margin | -16.4% | -111.2% | -866.2% | -1063.9% | -2096.9% |
| Interest Expense | $1M | $981K | $488K | $1M | $690K |
| Income Before Tax | -$2M | -$4M | -$3M | -$3M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$4M | -$3M | -$3M | -$3M |
| Net Margin | -32.2% | -124.8% | -1043.2% | -1637.6% | -3483.2% |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.00 |
| EBITDA | -$508K | -$3M | -$2M | -$151K | -$2M |
| Shares Outstanding | 366M | 398M | 429M | 461M | 592M |